144 related articles for article (PubMed ID: 24730278)
1. Strategies for combination of aptamer and targeted drug delivery.
Wang C; Liu B; Lu J; Zhang G; Lu A
J Nanosci Nanotechnol; 2014 Jan; 14(1):501-12. PubMed ID: 24730278
[TBL] [Abstract][Full Text] [Related]
2. Aptamer-functionalized nanoparticles for drug delivery.
Liu B; Zhang J; Liao J; Liu J; Chen K; Tong G; Yuan P; Liu Z; Pu Y; Liu H
J Biomed Nanotechnol; 2014 Nov; 10(11):3189-203. PubMed ID: 26000380
[TBL] [Abstract][Full Text] [Related]
3. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
Li X; Zhao Q; Qiu L
J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
[TBL] [Abstract][Full Text] [Related]
4. A DNA nanocapsule with aptamer-controlled open-closure function for targeted delivery.
Bentin T
Artif DNA PNA XNA; 2012; 3(1):3-4. PubMed ID: 22679527
[TBL] [Abstract][Full Text] [Related]
5. Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery.
Liao J; Liu B; Liu J; Zhang J; Chen K; Liu H
Expert Opin Drug Deliv; 2015 Mar; 12(3):493-506. PubMed ID: 25430795
[TBL] [Abstract][Full Text] [Related]
6. Aptamer applications for targeted cancer therapy.
Barbas AS; Mi J; Clary BM; White RR
Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
[TBL] [Abstract][Full Text] [Related]
7. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
Pangburn TO; Petersen MA; Waybrant B; Adil MM; Kokkoli E
J Biomech Eng; 2009 Jul; 131(7):074005. PubMed ID: 19655996
[TBL] [Abstract][Full Text] [Related]
8. Polyvalent mesoporous silica nanoparticle-aptamer bioconjugates target breast cancer cells.
Li LL; Yin Q; Cheng J; Lu Y
Adv Healthc Mater; 2012 Sep; 1(5):567-72. PubMed ID: 23184791
[TBL] [Abstract][Full Text] [Related]
9. Aptamers: new arrows to target dendritic cells.
Ganji A; Varasteh A; Sankian M
J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
[TBL] [Abstract][Full Text] [Related]
10. Biophysical characterization of layer-by-layer synthesis of aptamer-drug microparticles for enhanced cell targeting.
Tan KX; Danquah MK; Sidhu A; Lau SY; Ongkudon CM
Biotechnol Prog; 2018 Jan; 34(1):249-261. PubMed ID: 28699244
[TBL] [Abstract][Full Text] [Related]
11. Selection and Application of Aptamers and Intramers.
Avci-Adali M
Adv Exp Med Biol; 2016; 917():241-58. PubMed ID: 27236559
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic loaded nanocapsules functionalized with aptamer gates for targeted destruction of pathogens.
Kavruk M; Celikbicak O; Ozalp VC; Borsa BA; Hernandez FJ; Bayramoglu G; Salih B; Arica MY
Chem Commun (Camb); 2015 May; 51(40):8492-5. PubMed ID: 25891472
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic applications of synthetic nucleic acid aptamers.
Poolsup S; Kim CY
Curr Opin Biotechnol; 2017 Dec; 48():180-186. PubMed ID: 28582756
[TBL] [Abstract][Full Text] [Related]
14. Nucleic acid aptamers targeting cell-surface proteins.
Dua P; Kim S; Lee DK
Methods; 2011 Jun; 54(2):215-25. PubMed ID: 21300154
[TBL] [Abstract][Full Text] [Related]
15. Engineering liposomes and nanoparticles for biological targeting.
Jølck RI; Feldborg LN; Andersen S; Moghimi SM; Andresen TL
Adv Biochem Eng Biotechnol; 2011; 125():251-80. PubMed ID: 21049296
[TBL] [Abstract][Full Text] [Related]
16. Anti-FGFR1 aptamer-tagged superparamagnetic conjugates for anticancer hyperthermia therapy.
Jurek PM; Zabłocki K; Waśko U; Mazurek MP; Otlewski J; Jeleń F
Int J Nanomedicine; 2017; 12():2941-2950. PubMed ID: 28442904
[TBL] [Abstract][Full Text] [Related]
17. Application of aptamers for targeted therapeutics.
Ray P; Viles KD; Soule EE; Woodruff RS
Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):255-71. PubMed ID: 23563807
[TBL] [Abstract][Full Text] [Related]
18. The development and testing of aptamers for cancer.
Barbas AS; White RR
Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
[TBL] [Abstract][Full Text] [Related]
19. Aptamer-drug conjugation for targeted tumor cell therapy.
Donovan MJ; Meng L; Chen T; Zhang Y; Sefah K; Tan W
Methods Mol Biol; 2011; 764():141-52. PubMed ID: 21748638
[TBL] [Abstract][Full Text] [Related]
20. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.
Powell D; Chandra S; Dodson K; Shaheen F; Wiltz K; Ireland S; Syed M; Dash S; Wiese T; Mandal T; Kundu A
Eur J Pharm Biopharm; 2017 May; 114():108-118. PubMed ID: 28131717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
